110 related articles for article (PubMed ID: 28181928)
21. COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder.
Lee SY; Chen SL; Wang YS; Chang YH; Huang SY; Tzeng NS; Lee IH; Yeh TL; Yang YK; Lu RB
Behav Brain Res; 2013 Jan; 237():243-8. PubMed ID: 23026378
[TBL] [Abstract][Full Text] [Related]
22. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
[TBL] [Abstract][Full Text] [Related]
23. Interaction of COMT rs4680 and BDNF rs6265 polymorphisms on functional connectivity density of the left frontal eye field in healthy young adults.
Li W; Liu B; Xu J; Jiang T; Yu C
Hum Brain Mapp; 2016 Jul; 37(7):2468-78. PubMed ID: 27004987
[TBL] [Abstract][Full Text] [Related]
24. Association between genes, stressful childhood events and processing bias in depression vulnerable individuals.
Vrijsen JN; van Oostrom I; Arias-Vásquez A; Franke B; Becker ES; Speckens A
Genes Brain Behav; 2014 Jun; 13(5):508-16. PubMed ID: 24589356
[TBL] [Abstract][Full Text] [Related]
25. Dopaminergic and neurotrophic genetic polymorphisms modulate the implicit gender-science stereotype.
Luo YLL; Chen J; Wang Y; Li X; Cai H
Psych J; 2021 Jun; 10(3):364-373. PubMed ID: 33619907
[TBL] [Abstract][Full Text] [Related]
26. Using a cognitive endophenotype to identify risk genes for depression.
Haeffel GJ; Eastman M; Grigorenko EL
Neurosci Lett; 2012 Feb; 510(1):10-3. PubMed ID: 22240101
[TBL] [Abstract][Full Text] [Related]
27. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
Gupta M; Chauhan C; Bhatnagar P; Gupta S; Grover S; Singh PK; Purushottam M; Mukherjee O; Jain S; Brahmachari SK; Kukreti R
Pharmacogenomics; 2009 Feb; 10(2):277-91. PubMed ID: 19207030
[TBL] [Abstract][Full Text] [Related]
29. Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Anttila S; Huuhka M; Leinonen E; Rontu R; Mattila K; Lehtimäki T
Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):31-5. PubMed ID: 17036259
[TBL] [Abstract][Full Text] [Related]
30. Double dissociation of dopamine genes and timing in humans.
Wiener M; Lohoff FW; Coslett HB
J Cogn Neurosci; 2011 Oct; 23(10):2811-21. PubMed ID: 21261454
[TBL] [Abstract][Full Text] [Related]
31. The relationship between childhood abuse and dissociation. Is it influenced by catechol-O-methyltransferase (COMT) activity?
Savitz JB; van der Merwe L; Newman TK; Solms M; Stein DJ; Ramesar RS
Int J Neuropsychopharmacol; 2008 Mar; 11(2):149-61. PubMed ID: 17608961
[TBL] [Abstract][Full Text] [Related]
32. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
[TBL] [Abstract][Full Text] [Related]
33. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
Freire TF; Fleck MP; da Rocha NS
Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
[TBL] [Abstract][Full Text] [Related]
34. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders.
Enoch MA; White KV; Waheed J; Goldman D
Depress Anxiety; 2008; 25(5):383-92. PubMed ID: 17941097
[TBL] [Abstract][Full Text] [Related]
35. Genes and the parsing of cognitive processes.
Goldberg TE; Weinberger DR
Trends Cogn Sci; 2004 Jul; 8(7):325-35. PubMed ID: 15242692
[TBL] [Abstract][Full Text] [Related]
36. The catechol-O-methyltransferase gene: its regulation and polymorphisms.
Tunbridge EM
Int Rev Neurobiol; 2010; 95():7-27. PubMed ID: 21095457
[TBL] [Abstract][Full Text] [Related]
37. Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.
Papenberg G; Salami A; Persson J; Lindenberger U; Bäckman L
Neuropsychol Rev; 2015 Mar; 25(1):47-62. PubMed ID: 25666727
[TBL] [Abstract][Full Text] [Related]
38. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
[TBL] [Abstract][Full Text] [Related]
39. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychological correlates of transcription factor AP-2Beta, and its interaction with COMT and MAOA in healthy females.
Schabram I; Eggermann T; Siegel SJ; Gründer G; Zerres K; Vernaleken I
Neuropsychobiology; 2013; 68(2):79-90. PubMed ID: 23881096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
